{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:05:15Z","timestamp":1794506715145,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":28,"publisher":"Springer New York","isbn-type":[{"value":"9781493930074","type":"print"},{"value":"9781493930081","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3008-1_12","type":"book-chapter","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T05:46:27Z","timestamp":1444715187000},"page":"177-200","source":"Crossref","is-referenced-by-count":25,"title":["Generation and Selection of Orf Virus (ORFV) Recombinants"],"prefix":"10.1007","author":[{"given":"Hanns-Joachim","family":"Rziha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Amann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.79.23.7415","volume":"79","author":"M Mackett","year":"1982","unstructured":"Mackett M, Smith GL, Moss B (1982) Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci U S A 79:7415\u20137419","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1073\/pnas.79.16.4927","volume":"79","author":"D Panicali","year":"1982","unstructured":"Panicali D, Paoletti E (1982) Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc Natl Acad Sci U S A 79:4927\u20134931","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1016\/j.vaccine.2013.03.042","volume":"31","author":"B Moss","year":"2013","unstructured":"Moss B (2013) Reflections on the early development of poxvirus vectors. Vaccine 31:4220\u20134222","journal-title":"Vaccine"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1016\/j.vaccine.2013.05.091","volume":"31","author":"SJ Draper","year":"2013","unstructured":"Draper SJ, Cottingham MG, Gilbert SC (2013) Utilizing poxviral vectored vaccines for antibody induction-progress and prospects. Vaccine 31:4223\u20134230","journal-title":"Vaccine"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/156652311795684731","volume":"11","author":"CE Gomez","year":"2011","unstructured":"Gomez CE, Najera JL, Krupa M et al (2011) MVA and NYVAC as vaccines against emergent infectious diseases and cancer. Curr Gene Ther 11:189\u2013217","journal-title":"Curr Gene Ther"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1586\/erv.11.79","volume":"10","author":"SR Walsh","year":"2011","unstructured":"Walsh SR, Dolin R (2011) Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors. Expert Rev Vaccines 10:1221\u20131240","journal-title":"Expert Rev Vaccines"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1517\/14712598.2012.668516","volume":"12","author":"JW Kim","year":"2012","unstructured":"Kim JW, Gulley JL (2012) Poxviral vectors for cancer immunotherapy. Expert Opin Biol Ther 12:463\u2013478","journal-title":"Expert Opin Biol Ther"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/156652308784049363","volume":"8","author":"CE Gomez","year":"2008","unstructured":"Gomez CE, Najera JL, Krupa M et al (2008) The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer. Curr Gene Ther 8:97\u2013120","journal-title":"Curr Gene Ther"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.copbio.2004.09.001","volume":"15","author":"I Drexler","year":"2004","unstructured":"Drexler I, Staib C, Sutter G (2004) Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential? Curr Opin Biotechnol 15:506\u2013512","journal-title":"Curr Opin Biotechnol"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"7676","DOI":"10.1128\/JVI.02748-05","volume":"80","author":"R Chavan","year":"2006","unstructured":"Chavan R, Marfatia KA, An IC et al (2006) Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses. J Virol 80:7676\u20137687","journal-title":"J Virol"},{"key":"12_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/icb.2014.10","volume":"92","author":"TA Russell","year":"2014","unstructured":"Russell TA, Tscharke DC (2014) Strikingly poor CD8(+) T-cell immunogenicity of vaccinia virus strain MVA in BALB\/c mice. Immunol Cell Biol 92:466\u2013469","journal-title":"Immunol Cell Biol"},{"key":"12_CR12","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1128\/JVI.06684-11","volume":"86","author":"CE Gomez","year":"2012","unstructured":"Gomez CE, Perdiguero B, Najera JL et al (2012) Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV\/AIDS vaccine candidate NYVAC-C in mice. J Virol 86:5026\u20135038","journal-title":"J Virol"},{"key":"12_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016819","volume":"6","author":"ED Quakkelaar","year":"2011","unstructured":"Quakkelaar ED, Redeker A, Haddad EK et al (2011) Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. PLoS One 6, e16819","journal-title":"PLoS One"},{"key":"12_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025674","volume":"6","author":"KV Kibler","year":"2013","unstructured":"Kibler KV, Gomez CE, Perdiguero B et al (2013) Improved NYVAC-based vaccine vectors. PLoS One 6, e25674","journal-title":"PLoS One"},{"key":"12_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1439-0450.2002.00539.x","volume":"49","author":"M B\u00fcttner","year":"2002","unstructured":"B\u00fcttner M, Rziha H-J (2002) Parapoxviruses: from the lesion to the viral genome. J Vet Med B Infect Dis Vet Public Health 49:7\u201316","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"12_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/B978-012374410-4.00461-1","volume":"5","author":"D Haig","year":"2008","unstructured":"Haig D, Mercer AA (2008) Parapoxvirus. Encyclopedia Virol 5:57\u201363, Mahy BWJ, Van Regenmortel MHV (Eds) Elsevier, Oxford","journal-title":"Encyclopedia Virol"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0168-1656(00)00307-2","volume":"83","author":"H-J Rziha","year":"2000","unstructured":"Rziha H-J, Henkel M, Cottone R et al (2000) Generation of recombinant parapoxviruses: non-essential genes suitable for insertion and expression of foreign genes. J Biotechnol 83:137\u2013145","journal-title":"J Biotechnol"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"9312","DOI":"10.1128\/JVI.77.17.9312-9323.2003","volume":"77","author":"T Fischer","year":"2003","unstructured":"Fischer T, Planz O, Stitz L et al (2003) Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice. J Virol 77:9312\u20139323","journal-title":"J Virol"},{"key":"12_CR19","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1128\/JVI.79.1.314-325.2005","volume":"79","author":"M Henkel","year":"2005","unstructured":"Henkel M, Planz O, Fischer T et al (2005) Prevention of virus persistence and protection against immunopathology after Borna disease virus infection of the brain by a novel Orf virus recombinant. J Virol 79:314\u2013325","journal-title":"J Virol"},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.vaccine.2006.05.078","volume":"24","author":"D Dory","year":"2006","unstructured":"Dory D, Fischer T, Beven V et al (2006) Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (Herpes suid 1). Vaccine 24:37\u201339","journal-title":"Vaccine"},{"key":"12_CR21","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.vaccine.2009.12.004","volume":"28","author":"EM van Rooij","year":"2010","unstructured":"van Rooij EM, Rijsewijk FA, Moonen-Leusen HW et al (2010) Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs. Vaccine 28:1808\u20131813","journal-title":"Vaccine"},{"key":"12_CR22","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1016\/j.vaccine.2007.05.035","volume":"25","author":"H Voigt","year":"2007","unstructured":"Voigt H, Merant C, Wienhold D et al (2007) Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2). Vaccine 25:5915\u20135926","journal-title":"Vaccine"},{"key":"12_CR23","doi-asserted-by":"publisher","first-page":"9256","DOI":"10.1016\/j.vaccine.2011.09.121","volume":"29","author":"J Rohde","year":"2011","unstructured":"Rohde J, Schirrmeier H, Granzow H et al (2011) A new recombinant Orf virus (ORFV, Parapoxvirus) protects rabbits against lethal infection with rabbit hemorrhagic disease virus (RHDV). Vaccine 29:9256\u20139264","journal-title":"Vaccine"},{"key":"12_CR24","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1128\/JVI.02470-12","volume":"87","author":"R Amann","year":"2013","unstructured":"Amann R, Rohde J, Wulle U et al (2013) A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein. J Virol 87:1618\u20131630","journal-title":"J Virol"},{"key":"12_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083802","volume":"8","author":"J Rohde","year":"2013","unstructured":"Rohde J, Amann R, Rziha HJ (2013) New Orf virus (Parapoxvirus) recombinant expressing H5 hemagglutinin protects mice against H5N1 and H1N1 influenza A virus. PLoS One 8, e83802","journal-title":"PLoS One"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/nprot.2007.226","volume":"2","author":"M Zeitelhofer","year":"2007","unstructured":"Zeitelhofer M, Vessey JP, Xie Y et al (2007) High-efficiency transfection of mammalian neurons via nucleofection. Nat Protoc 2:1692\u20131704","journal-title":"Nat Protoc"},{"key":"12_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0168-1656(99)00141-8","volume":"73","author":"HJ Rziha","year":"1999","unstructured":"Rziha HJ, Henkel M, Cottone R et al (1999) J Biotechnol 73:235\u2013242","journal-title":"J Biotechnol"},{"key":"12_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0166-0934(91)90129-N","volume":"35","author":"L Pasamontes","year":"1991","unstructured":"Pasamontes L, Gubser J, Wittek R et al (1991) Direct identification of recombinant vaccinia virus plaques by PCR. J Virol Methods 35:137\u2013141","journal-title":"J Virol Methods"}],"container-title":["Methods in Molecular Biology","Vaccine Technologies for Veterinary Viral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3008-1_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T15:55:28Z","timestamp":1676649328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-3008-1_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493930074","9781493930081"],"references-count":28,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3008-1_12","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-3008-1","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}